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The aim of this research was to find out in vitro antiplasmodium activity of malacca leaves (Phyllantus emblica) ethanolic extract against 
Plasmodium falciparum growth. In this study, Plasmodium culture contained 5% parasitemia in ring stage was cultured using candle jar method 
and antiplasmodial activity test was carried out using microculture. The treatments were divided into 7 groups with four repetitions. K1 as 
negative control group was given Roswell Park Memorial Institute (RPMI), while K2 as positive control group was given artesdiaquine. Groups 
K3, K4, K5, K6, and K7 were added with 100 µg/mL, 75 µg/mL, 50 µg/mL, 25 µg/mL, and 5 µg/mL of malacca leaves ethanolic extract, 
respectively. Antiplasmodial activity was determined by inhibition concentration of 50% parasite growth (IC50). The data were analyzed using 
ANOVA and followed by Duncan test. The average of parasitemia level in group K1 , K2, K3, K4, K5, K6, and K7 were 55.25±15.62, 8.50±2.52, 
8.50±3.00, 9.25±0.95, 9.00±2.70, 9.79±2.06, and 10.75±2.22, respectively. The average of inhibition percentage in group K1, K2, K3, K4, K5, 
K6, and K7 were 0.00±0.00%, 84.62±4.55%, 84.62±5.43%, 83.26±1.73%, 83.71±4,90%, 82.35±3,73%, and 80.54±6.83%, respectively (P<0.01). 
The results showed that the administration of malacca leaves ethanolic extract significantly affect (P<0.01) the inhibition of Plasmodium growth 
as compared to group K1 (negative control).  Probit analysis reveals the IC50 value was 3.889 µg/mL. In conclusion, all doses of malacca leaves 
ethanolic extract used in this study was able to inhibit Plasmodium falciparum growth with IC50 value was 3.889 µg/mL. 
____________________________________________________________________________________________________________________ 




Penelitian ini bertujuan mengetahui pengaruh ekstrak etanol daun malaka (Phyllantus emblica) terhadap pertumbuhan Plasmodium 
falciparum secara in vitro. Penelitian ini menggunakan kultur Plasmodium stadium cincin dengan konsentrasi parasitemia 5%. Kultur 
Plasmodium menggunakan metode candle jar dan uji aktivitas Plasmodium dilakukan dengan metode mikrokultur. Kelompok perlakuan dibagi 
menjadi 7 kelompok dengan 4 kali pengulangan. Kelompok K1 sebagai kontrol negatif diberikan Roswell Park Memorial Institute (RPMI), 
sedangkan K2 sebagai kontrol positif diberikan artesdiakuin. Kelompok  K3, K4, K5, K6, dan K7 masing-masing diberikan ekstrak etanol daun 
malaka dengan dosis 100, 75, 50, 25, dan 5 µg/ml. Aktivitas antiplasmodium dinyatakan dengan nilai inhibition concentration (IC50) yaitu 
kemampuan menghambat 50% pertumbuhan Plasmodium. Data yang diperoleh dianalisis dengan analisis varians (ANAVA) dan dilanjutkan 
dengan uji Duncan. Rerata parasitemia pada K1; K2; K3; K4; K5; K6; dan K7 masing-masing adalah 55,25±2,75; 8,50±2,52; 8,50±3,00; 
9,25±0,96; 9,00±2,71; 9,75±2,06; dan 10,75±2,22. Rerata persentase hambatan pada K1; K2; K3; K4; K5; K6; dan K7 masing-masing adalah 
0.00±0.00%; 84,62% ±4,55; 84,62%±5,43; 83,26%±1,73; 83,71%±4,90; 82,35%±3,73; dan 80,54%±6,83 (P<0,01). Uji lanjut menunjukkan 
bahwa perlakuan K2, K3, K4, K5, K6, dan K7
 berpengaruh sangat nyata (P<0,01) terhadap penghambatan pertumbuhan plasmodium dibandingkan 
dengan kelompok  K1. Hasil analisis probit menujukkan bahwa nilai IC50 sebesar 3,889 µg/ml. Disimpulkan bahwa semua dosis ekstrak etanol 
daun malaka dapat menghambat pertumbuhan Plasmodium falciparum dengan nilai IC50 value adalah 3.889 µg/ml. 
____________________________________________________________________________________________________________________ 




Malaria is an infectious disease caused by 
intracellular protozoa named Plasmodium, which is 
transmitted through the bite of a female Anopheles 
mosquito (Arsin, 2012). Malaria can cause death, 
especially in high-risk groups, i.e.: infants, toddlers, 
and pregnant women, it also directly cause anemia and 
reduce work productivity. In 2013, the national malaria 
prevalence rate was 6.0%, with 15 provinces having a 
prevalence above the national average including Aceh 
and the highest prevalence was found in Eastern 
Indonesia, i.e.: Papua (28.6%), East Nusa Tenggara 
(23,3%), West Papua (19.4%), Central Sulawesi 
(12.5%), and Maluku (10.7%) (Departemen Kesehatan 
RI, 2013). 
The resistance of malaria treatment to conventional 
drugs such as chloroquine and sulfadoxine-
pyrimethamine leads to further complicates efforts to 
eradicate malaria. The report on malaria treatment 
resistance to previous drugs (chloroquine, sulfadoxin-
pyrimethamine, and quinine) occur in more than 25% 
of provinces in Indonesia in the last 10 years, therefore 
new steps are needed in the treatment of malaria 
(Harijanto, 2011). One of the solutions that should be 
taken is to conduct research to find a new drug 
substance in plants which inhibit or kill malaria-
causing parasites. The fruit, leaves, stems or plant roots 
has beeb known to contain secondary metabolites 
which can be used as antimalaria. 
Malacca (Phyllanthus emblica) is a plant that can 
cure various diseases (Khan, 2009; Kaur et al., 2013). 
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Previous studies mentioned that malacca can be used as 
an anti-oxidant (Charoenteeraboon et al., 2010), 
hepatoprotector (Malar and Mary, 2009), analgesic and 
antipyretic (James et al., 2004), anti-cancer (Singh et 
al., 2015), anti-inflammatory (Nicolis et al., 2008; 
Dang et al., 2011), and also can reduce blood glucose 
levels (Qureshi et al., 2009). Pinmai et al. (2010) 
reported that malacca fruit extract has anti-Plasmodium 
activity.  
The phytochemical content of malacca leaves 
ethanolic extract includes alkaloids, flavonoids, 
tannins, saponins, phenols, and glycosides (Ravikumar 
et al., 2012). The extract of malacca leaf is also 
effective as chemo-protector (Singh et al., 2011), anti-
tumor (Ngamkitidechakul et al., 2010; Sumalatha, 
2013), antimicrobial, antibacterial, antifungal (Malliga 
et al., 2015; Singh et al., 2015), antiviral, 
antimutagenic, anti-allergic (Khopde et al., 2001), and 
antimalaria (Ravikumar et al., 2012). This study was 
designed to find out in vitro antiplasmodium activity of 
malacca leaves (Phyllantus emblica) ethanolic extract 
against Plasmodium falciparum growth. 
 
MATERIALS DAN METHODS 
 
This study used a complete randomized design 
(CRD) with 7 treatment groups and 4 repetitions. The 
K1 group as a negative control was administered with 
Roswell Park Memorial Institute (RPMI), while group 
K2 as a positive control was administered with 
artediasquine. Groups K3, K4, K5, K6, and K7 were 
administered with ethanolic extract of malacca leaves 
at doses of 100, 75, 50, 25, and 5 µg/mL, respectively. 
 
Malacca Leaf Extraction 
Malacca leaves used in this study were obtained 
from Aceh Besar area, which has been identified by 
Biological Herbarium of Mathematics and Natural 
Science Faculty, Universitas Syiah Kuala. Leaves that 
grow from the base to the tip of the branch were 
collected and air dried. The leaves were then cleaned 
from twigs and foreign objects, grinded and sieved 
with a 40 mesh sieve. As much as 1.5 kg malacca leaf 
powder was macerated using ethanol solvent for 24 
hours until a clear solution was obtained. The 
macerated solution was filtered using filter paper, then 
the filtrate was collected and evaporated using a 
rotary evaporator until all the solvents evaporated and 
paste form extract was obtained. 10 mg ethanolic 
extract of malacca leaves was dissolved in 5 mL 
sterile double distilled water, homogenized and stored 
as a stock solution. The solution was then diluted into 
various doses of test compounds with the 
concentrations of 100, 75, 50, 25, and 5 µg/mL. 
 
Medium Preparation 
Roswell Park Memorial Institute media was made 
by mixing 10.4 g RPMI (Gibco1640, powder) and 5.94 
g hydroxyethyl piperazineethanesulfonic acid 
(HEPES), then 1000 mL distilled water was added, 
stirred with the stirrer, and added 50 mg/L gentamycin. 
The solution was then sterilized with a 0.22 µm filter, 
divided into 4 bottles and stored in a refrigerator. The 
transport medium was made by mixing 100 mL of 
RPMI media with 5% NaHCO3, then homogenized and 
sterilized using a 0.22 µm filter. Roswell Park Human 
Serum (RPHS) culture medium was prepared from 100 
mL RPMI medium, which was added with 4.2 mL of 
NaHCO3 and 11.5 mL of AB blood type serum, then 
sterilized with a 0.45 µm filter and stored in a 
refrigerator. 
 
Blood Serum Preparation 
A total of 50 mL vein blood was collected and put 
into a sterile tube, then stored in an incubator at 37 C 
in an inclined state (forming a 15 angle) for 1-2 hours. 
Then, the blood was put into the refrigerator for 12 
hours. The blood was centrifuged at a speed of 1500 
rpm for 10 minutes. The serum taken and inserted in a 
test tube, then inactivated in a water bath at a 
temperature of 56 C for 1 hour. The serum was stored 
at -20 C until it was ready to use. 
 
Preparation of Fresh Erythrocyte 
A total of 10 mL of fresh blood was collected into a 
tube that had been given citrate phosphate dextrose 
(CPD) anticoagulant, then homogenized slowly and 
centrifuged at 1500 rpm for 15 minutes. The 
supernatant was discarded, and the sediment (blood 
objects) was washed with transport media 2 times, then 
shaken slowly and centrifuged for 15 minutes at a 
speed of 1500 rpm. After that, the supernatant was 
removed and the precipitate was mixed with RPHS 
(1:1) and stored in a refrigerator. 
 
Culture Preparation 
Plasmodium falciparum stock was thawed by 
placing in waterbath or rubbed by hand. Then it was 
put into a 15 mL centrifuge tube and washed with 3.5% 
NaCl, centrifuged for 10 minutes with a speed of 1500 
rpm. The supernatant was removed and the pellet 
obtained was washed with AB blood serum. 
Subsequently, the pellet was washed again with 
transport media 3 times. Finally, the package cell 
volume (PCV) was calculated. 
 
Antiplasmodium Potential Test for Malacca Leaves 
Extract 
Plasmodium falciparum culture used was at ring 
stage with 5% parasitemia concentration and 5% 
hematocrit. The ring stage was obtained by 
synchronizing using a 5% sorbitol solution. Each well 
plate was filled with 10 µL of test extract and 190 µL of 
culture medium containing Plasmodium at ring stage. 
Negative control was given RPMI, positive control was 
given artesdiaquine, and the other five groups given 
ethanolic extract of malacca leaves with the dose of 100, 
75, 50, 25, and 5 µg/mL. The plate was subsequently 
closed and stirred slowly to mix perfectly. Finally, the 
plate was put in a candle jar and incubated at 37 C for 
48 hours. 
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Giemsa Staining   
Thin blood smear was carried out on the object 
glass for each plate. Then dried, washed with PBS, and 
fixed with glutaraldehyde, and dried in an incubator. 
Then, 5% Giemsa was added and let dry for 30 
minutes, washed with distilled water and dried. 
Parasitemia Count 
The amount of parasitemia was observed and 
counted under a microscope with 1000x magnification 
(Sardjono and Fitri, 2007). The percentage of 
parasitemia and the percentage of the inhibition were 




Xe   Percentage of the average growth of parasites in 
each treatment 




The data obtained were analyzed using one way 
analysis of variance (ANOVA) and continued with 
Duncan multiple range tests. Determination of IC50 
values was performed by probit analysis. 
 
RESULTS AND DISCUSSION 
 
The number of parasitemia in group K1, K2, K3, 
K4, K5, K6, and K7 are shown in Table 1. Based on 
Table 1, the mean of parasitemia numerically increased 
as the dose of malacca leaves ethanolic extract 
decreased. The highest mean of parasitemia was 
observed in K7 which given the lowest concentration of 
malacca leaf extract, while the lowest mean of 
parasitemia was observed in K3 which given the 
highest dose of the extract. The results showed that all 
the treatments were significantly different (P<0.01) 
from negative control. The results of Duncan test 
showed that K1 (negative control) was significantly 
different (P<0.01) from K2, K3, K4, K5, K6, and K7, 
while K3 was not significantly different (P>0.05) from 
K2, K4, K5, K6, and K7. These results indicate that 
there are no significant differences among treatment 
groups administered with ethanolic extract of malacca 
leaves.  
The percentage of parasitemia dan inhibition rate of 
Plasmodium are presented in Table 2. The inhibition 
rate of Plasmodium by ethanolic extract of malacca 
leaves increased with the increasing dose given, except 
K4 which decreased 0.5% from K5. The highest 
inhibition rate was 84.62±5.43% found in K3 (100 
µg/mL), while the lowest inhibition was 80.54±6.83% 
found in K7 (5 µg/mL). The group which was given 
100 µg/mL ethanolic extract (84.63±5.43%) had 
similar ability compared to group given artesdiaquine 
(84.62±4.55%) in inhibiting Plasmodium growth. 
The results showed that the highest the dose of 
extract that have been used, the highest the inhibition of 
Plasmodium growth. All doses of malacca leaves 
ethanolic extract used in this study showed the 
inhibition rate more than 80% towards Plasmodium 
growth. Pouplin et al. (2007) stated that an extract is 
considered to have an antiplasmodium properties if it 
can inhibit more than 30% parasite, indicated that all 
doses of malacca leaves ethanolic extract used in study 
have antiplasmodium properties. 
To assess the relationship between the increased of 
concentration and the inhibitory activity on the growth 
of Plasmodium falciparum, the percentage of inhibition 
data was analyzed using probit analysis to obtain the 
value of inhibition concentration (IC50). The results of 
IC50 analysis showed that the ability of ethanolic 
extract of malacca leaves concentration in inhibiting 
50% Plasmodium falciparum growth in erythrocytes in 
vitro was found at a dose of 3.889 µg/mL. 
Ravikumar et al. (2012), reported that the 
antiplasmodium activity of the test substance in vitro 
was divided into 4, i.e: test substances with very active 
activity if IC50 <5 µg/mL, active activity when IC50 
Table 1. Mean of parasitemia in 1000 erythrocytes  
Groups Mean (±SD) 
K1 (Negative control) 55.25±2.75a 
K2 (Positive control) 8.50±2.52b 
K3 (Ethanolic extract of malacca leaves dose 100 µg/mL) 8.50±3.00b 
K4 (Ethanolic extract of malacca leaves dose 75 µg/mL) 9.25±0.96b 
K5 (Ethanolic extract of malacca leaves dose 50 µg/mL) 9.00±2.71b 
K6 (Ethanolic extract of malacca leaves dose 25 µg/mL) 9.75±2.06b 
K7 (Ethanolic extract of malacca leaves dose 5 µg/mL) 10.75±2.22b 
a,bDifferent superscripts within the same column indicate significant differences (P<0.01) 
 







K1 (Negative control) 5.25±0.28 0.00±0.00 
K2 (Positive control) 0.85±0.25 84.62±4.55 
K3 (Ethanolic extract of malacca leaves dose 100 µg/mL) 0.85±0.30 84.63±5.43 
K4 (Ethanolic extract of malacca leaves dose 75 µg/mL) 0.93±0.10 83.26±1.73 
K5 (Ethanolic extract of malacca leaves dose 50 µg/mL) 0.90±0.27 83.71±4.90 
K6 (Ethanolic extract of malacca leaves dose 25 µg/mL) 0.98±0.21 82.35±3.73 
K7 (Ethanolic extract of malacca leaves dose 5 µg/mL) 1.08±0.22 80.54±6.83 
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values were between 5-50 µg/mL, very low activity if 
IC50 values are 50-100 µg/mL, and not active if 
IC50>100 µg/mL. Based on these findings, it can be 
concluded that the administration of ethanolic extract 
of malacca leaves has a very active activity in 
inhibiting the growth of Plasmodium falciparum with 
IC50 value was 3.889 µg/mL. The IC50 value obtained 
in this study was different from which was reported by 
Ravikumar et al. (2012), which found the IC50 was 
35.09 µg/mL. This difference is likely to occur due to 
differences in the area where malacca grows and the 
method of extraction used.  
Malacca leaves contains secondary metabolites, 
such as alkaloids, flavonoids, tannins, saponins, 
phenols, glycosides, or carbohydrates which have 
ability to inhibit the growth of Plasmodium (Dhale and 
Mogle, 2011; Ravikumar et al., 2012). According to 
Tasdemir et al. (2007), plant secondary metabolites, 
such as alkaloids, can inhibit biosynthesis of fatty acid 
and inhibit the biocrystallization of hemozoin in 
Plasmodium falciparum (Dubar et al., 2010). 
Carbohydrates also can inhibit the invasion of 
Plasmodium merozoites into erythrocytes (Adams et 
al., 2005), and interfere with the formation of the 
Plasmodium falciparum rosette (Rowe et al., 1994). 
Plant secondary metabolite compound also have 
antiplasmodium activity which increase the oxidation of 
red blood cells or inhibit protein synthesis (Phillipson 
and Wright, 1991). According to Rinidar et al. (2013), 
the in vitro antiplasmodium activity occur probably 
caused by the presence of terpenoids in plants which are 
thought to prevent the division of the trophozoite nucleus 
into schizont in Plasmodium after incubated for 24-36 
hours. However, the most active phytochemical 
compounds in malacca leaves that act as antiplasmodium 
and its mechanism have not been evaluated in this study. 
Therefore, further study is needed to find out the 




All doses of malacca leaves ethanolic extract used 
in this study were able to inhibit Plasmodium 
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